To investigate if Srebf-mediated cholesterol and fatty acid synthesis are implicated in the survival of T cell lymphoma cells from Lck-Dlx5;Lck-MyrAkt2 mice, cells were treated with the cholesterol biosynthesis inhibitors RO48-8071 or simvastatin. The gene discussed is DLX5; the disease is T-cell non-Hodgkin lymphoma.